PLx Pharma upgraded by Raymond James with a new price target
$PLXP
Biotechnology: Pharmaceutical Preparations
Health Care
Raymond James upgraded PLx Pharma from Market Perform to Outperform and set a new price target of $14.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/7/2021 | $14.00 | Market Perform → Outperform | Raymond James |
| 9/21/2021 | $29.00 | Buy | BWS Financial |